Cellebrite DI (CLBT) Change in Accured Expenses (2020 - 2025)

Cellebrite DI's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $6.8 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 41.9% year-over-year to $6.8 million; the TTM figure through Dec 2025 stood at $24.0 million (up 36.48% YoY), while the FY2025 annual figure was $4.2 million, down 75.84% from the prior year.
• Change in Accured Expenses was $6.8 million for Q4 2025 at Cellebrite DI, down from $17.6 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $17.6 million in Q2 2025 to a low of -$12.2 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $1.4 million across 5 years, with a median of $2.4 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 184.84% in 2022, then surged 809.28% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $2.4 million in 2021, then tumbled by 184.84% to -$2.1 million in 2022, then surged by 370.44% to $5.6 million in 2023, then surged by 110.41% to $11.7 million in 2024, then slumped by 41.9% to $6.8 million in 2025.
• The last three Change in Accured Expenses figures came in at $6.8 million (Q4 2025), $17.6 million (Q2 2025), and -$12.2 million (Q1 2025), per Business Quant data.